InsightsStay informed and get inspired with latest interviews
from industry leaders.
Tell us more about your current role. I’m a general partner at TVM Capital based in Munich. I’ve been with the company now for five years but much longer in this industry. I used to be a working student at TVM and stayed in touch ever since. I’m very active in screening the life science landscape in Europe and North America and invest predominantly in pharmaceutical opportunities. We focus on new drugs, starting from a late preclinical stage to companies at fairly advanced
Can you tell us more about Carity? What does the company do and why? Carity was born at the end of 2019 as a project that was based on the observation that one-third to 40% of post-heart attack patients that go to outpatient cardiac rehabilitation suffer from depression and anxiety. This is a major hurdle
Tell us more about your role with ACM BioSciences. When approached by a board member of ACM BioSciences in spring with the idea of supporting them with their partnering activities, after several meetings and reflecting on the requests, I convinced the management that there was another gap in their organisation. At the end I agreed to
Tell us more about GeneLook. GeneLook came from a vision with two other co-founders to address the needs of patients, healthcare providers, academic researchers, and the biopharma industry in the usage and sharing of genetic data to build the future of precision medicine while simultaneously accelerating the development of new drugs/treatments. Genetic testing for health
Tell us more about your background. I grew up in Poland and came to the UK about 7 years ago. My background is in civil engineering and IT. I used to work for many years as a product owner for tech support companies, software houses and seed startups, before moving into the business side and working as a
Could you share with us an overview of your career? My career of 25 years started back in the mid-90s as an Investment Banker helping companies from Asia execute public listings in international stock markets and M&A transactions. Upon moving to Switzerland in 2000, I started covering the healthcare sector as a healthcare banker. As